DHX40 Gene: DEAH-Box Helicase 40 – Function, Expression, and Clinical Significance

A comprehensive biomedical overview of DHX40, including genomic context, protein function, expression profiles, and disease associations.

Gene Information Card

Symbol DHX40
Full Name DEAH-box helicase 40
Gene Type protein-coding
Chromosomal Location 17q23.1
NCBI Gene ID 79665 ncbi.nlm.nih.gov/gene/79665
Ensembl ID ENSG00000108771
UniProt ID Q5T1M5
OMIM ID 617057
HGNC ID 20619
Aliases FLJ13910, MGC126851

Description

DHX40 encodes a member of the DEAH-box family of RNA helicases. These proteins are involved in ATP-dependent RNA unwinding, which is critical for RNA splicing, ribosome biogenesis, and gene expression regulation. DHX40 is localized to the nucleus and is ubiquitously expressed, with higher levels in tissues with active RNA metabolism. Its precise cellular functions are still under investigation, but it is implicated in pre-mRNA processing and may play a role in cancer and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various) Altered expression and potential dysregulation of RNA helicase activity may affect RNA processing and cell proliferation. COSMIC lists somatic mutations in DHX40 across multiple cancer types, but functional validation is limited.
Neurodevelopmental disorders Rare variants in DHX40 have been reported in patients with intellectual disability, but the mechanism is not fully established. ClinVar has a few entries with uncertain significance; no definitive OMIM disease association.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 25.1 High
Thyroid 18.3 Medium
Adrenal gland 15.7 Medium
Brain (cerebellum) 12.4 Medium
Liver 8.2 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 20.5 High expression; consistent with active RNA metabolism
HeLa (cervical cancer) 15.2 Moderate expression
A549 (lung carcinoma) 12.8 Moderate expression
HepG2 (hepatocellular carcinoma) 9.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234A>G (p.Lys412Glu) Missense 0.01% (gnomAD) Unknown; predicted benign by in silico tools
c.567_568del (p.Glu190fs) Frameshift Rare Likely loss of function; may affect helicase activity
c.890C>T (p.Thr297Met) Missense 0.02% (gnomAD) Uncertain significance; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations likely lead to truncated protein and loss of helicase activity, potentially impairing RNA processing.

Gain of Function (GOF)

No evidence for gain-of-function mutations; most variants are loss-of-function or neutral.

Dominant Negative (DN)

No known dominant-negative effects; DHX40 is not a well-characterized tumor suppressor or oncogene.

Gene Ontology (GO)

• ATP binding • RNA helicase activity
• nucleic acid binding • nucleus
• mRNA processing • RNA secondary structure unwinding

Pathways

mRNA Splicing - Major Pathway
Processing of Capped Intron-Containing Pre-mRNA

Protein Summary

DHX40 is a 120 kDa protein consisting of 1088 amino acids. It contains a conserved DEAH-box helicase domain that binds ATP and unwinds RNA duplexes. The protein is predominantly nuclear and is thought to participate in spliceosome assembly and pre-mRNA splicing. Its expression is ubiquitous, with enrichment in tissues with high transcriptional activity. Structural studies suggest a typical helicase fold with two RecA-like domains. Post-translational modifications include phosphorylation, but their functional impact is not fully characterized.

Related Products

Product name Cat.No. Species Gene ID
DHX40 Knockout HEK293 Cell Line EDJ-KQ13151 Human 79665 Details Get a Quote
DHX40 Knockout A-549 Cell Line EDJ-KQ42486 Human 79665 Details Get a Quote
DHX40 Knockout HCT 116 Cell Line EDJ-KQ42487 Human 79665 Details Get a Quote
DHX40 Knockout HeLa Cell Line EDJ-KQ42488 Human 79665 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: